Adherence to diabetes medication among diabetic patients in the Bisha governorate of saudi Arabia – a cross-sectional survey

Background: Patients’ non-adherence to diabetes medication is associated with poor glycemic control and suboptimal benefits from their prescribed medication, which can lead to worsening of medical condition, development of comorbidities, reduced quality of life, elevated health care costs, and increased mortality. Objective: This study aimed to assess medication adherence among patients with diabetes and associated factors in Bisha primary health care centers (PHCCs) in Saudi Arabia. Patients and methods: A cross-sectional study was conducted with a sample of 375 type 1 and 2 Saudi diabetic patients attending PHCCs under the Health Affairs of the Bisha governorate. The participants were aged 18 years and above, and had been taking diabetes medications for at least 3 months. Pregnant women, patients with mental illnesses, and those who were not willing to participate were excluded. Adherence to diabetes medications was measured using the four-item Morisky Green Levine Medication Adherence Scale (MGLS). All participants completed a self-report questionnaire including sociodemographic and clinical variables. Univariate and multivariate analyses were carried out using SPSS version 22. Results: Of all the respondents, 134 (35.7%), 161 (42.9%), and 80 (21.4%), patients had high (MGLS score 0), intermediate (MGLS score 1 or 2), and low adherence (MGLS score $ 3), respectively. Factors associated with the level of adherence in univariate analysis were occupational status ( P = 0.037), current medication ( P , 0.001), glycated hemoglobin (A1c) ( P , 0.001), and number of associated comorbidities ( P , 0.001). In multivariable analyses, A1c , 7 ( P , 0.001) and no associated comorbidities ( P , 0.003) variables remained significantly associated with adherence. Conclusion: The level of adherence to medication in diabetes mellitus patients in the Bisha PHCCs was found to be suboptimal. The findings point toward the need for better management of primary health care providers’ approaches to individual patients, by taking into account their medication adherence levels. Better identification of patients’ level of adherence remains essential for successful diabetes treatment.

[1]  A. Alqarni,et al.  Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia – a cross-sectional survey , 2018, Patient preference and adherence.

[2]  Ping Zhang,et al.  Economic Costs of Diabetes in the U.S. in 2017 , 2018, Diabetes Care.

[3]  A. Elsous,et al.  Medications Adherence and Associated Factors among Patients with Type 2 Diabetes Mellitus in the Gaza Strip, Palestine , 2017, Front. Endocrinol..

[4]  M. Alrefai.,et al.  Drug Compliance among Type 2 Diabetic patients in Jazan Region, Saudi Arabia. , 2017 .

[5]  Standards of Medical Care in Diabetes—2017: Summary of Revisions , 2016, Diabetes Care.

[6]  C. Huber,et al.  Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland , 2016, Patient preference and adherence.

[7]  K. Shamsuddin,et al.  Reliability and known-group validity of the Arabic version of the 8-item Morisky Medication Adherence Scale among type 2 diabetes mellitus patients. , 2015, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[8]  Paula Fresco,et al.  Medication Adherence Measures: An Overview , 2015, BioMed research international.

[9]  W. Nilsen,et al.  Self-report measures of medication adherence behavior: recommendations on optimal use , 2015, Translational behavioral medicine.

[10]  W. Herman,et al.  Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database , 2015, Diabetes Care.

[11]  B. Jimmy,et al.  Adherence to Medications among Type 2 Diabetes Mellitus Patients in Three Districts of Al Dakhliyah Governorate, Oman: A cross-sectional pilot study. , 2014, Sultan Qaboos University medical journal.

[12]  G. Rwegerera Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study , 2014, The Pan African medical journal.

[13]  D. Morisky,et al.  Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea , 2013, The Journal of international medical research.

[14]  Thomas Paraidathathu,et al.  Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia , 2013, Patient preference and adherence.

[15]  J. Viel,et al.  Medication Adherence in Type 2 Diabetes: The ENTRED Study 2007, a French Population-Based Study , 2012, PloS one.

[16]  Regina M. Benjamin,et al.  Medication Adherence: Helping Patients Take Their Medicines as Directed , 2012, Public health reports.

[17]  N. Wabe,et al.  Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia , 2011, North American journal of medical sciences.

[18]  Enaase A. M. E. Barakat,et al.  Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt. , 2010, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[19]  N. Wareham,et al.  Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. , 2009, Diabetes research and clinical practice.

[20]  J. Kalyango,et al.  Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors. , 2008, African health sciences.

[21]  A. Lippman Adherence to medication. , 2005, The New England journal of medicine.

[22]  D. Feeny,et al.  Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey , 2005, Quality of Life Research.

[23]  J. Cramer A systematic review of adherence with medications for diabetes. , 2004, Diabetes care.

[24]  Kathleen King,et al.  Medication Adherence and Associated Hemoglobin A1c in Type 2 Diabetes , 2004, The Annals of pharmacotherapy.

[25]  F. Camacho,et al.  Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. , 2003, Clinical therapeutics.

[26]  John D. Voss,et al.  The association between diabetes metabolic control and drug adherence in an indigent population. , 2002, Diabetes care.

[27]  Y. Al-Khaldi,et al.  Audit of referral of diabetic patients. , 2002, Saudi medical journal.

[28]  R C Peveler,et al.  Compliance with tricyclic antidepressants: the value of four different methods of assessment. , 2000, British journal of clinical pharmacology.

[29]  Andrew Mackinnon,et al.  A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement , 2000, Comput. Biol. Medicine.

[30]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[31]  THE WORLD HEALTH ORGANIZATION , 1954 .

[32]  A. K. Alhowaish Economic costs of diabetes in Saudi Arabia , 2013, Journal of family & community medicine.

[33]  Ataur R. Khan,et al.  Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia , 2012, Journal of family & community medicine.

[34]  Mulugeta Gebregziabher,et al.  Longitudinal effects on costs and potential cost savings from improvement , 2012 .

[35]  C. Asche,et al.  A review of diabetes treatment adherence and the association with clinical and economic outcomes. , 2011, Clinical therapeutics.

[36]  Stacey M. Lavsa,et al.  Selection of a validated scale for measuring medication adherence. , 2011, Journal of the American Pharmacists Association : JAPhA.

[37]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[38]  B. Rivera-Chavira,et al.  [Pharmacological therapy compliance in diabetes]. , 2001, Salud publica de Mexico.